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1 These authors contributed equally to this work.Triad 1 (2 RING [really interesting new gene] ﬁngers and DRIL [double RING ﬁnger linked] 1) is an E3
ligase that induces apoptosis and clonogenic inhibition in myeloid cells through Gﬁ-1 stabilization.
Here we demonstrate that Triad 1 induces apoptosis in several cancer cell lines including MCF7,
A549, U2OS, and HCT 116 p53+/+ cells via its RING ligase activity. Interestingly, in these cancer cells,
Triad 1-induced apoptosis is not mediated by Gﬁ-1 stabilization but is instead p53-dependent. More-
over, Triad 1 promotes transactivation of p53. These results suggest that Triad 1 can induce apopto-
sis through its ligase activity via p53 activation.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Although p53 is a protein of many roles including differentia-
tion, cell cycle arrest, and senescence, it is predominantly known
for its role in apoptosis [1]. Activation of p53 by various stimuli,
such as UV, hypoxia, and nutrient depletion, results in apoptosis.
Both transcriptional-dependent and -independent activation of
p53 is sufﬁcient for triggering apoptosis [2,3]. In addition, p53 is
modulated by post-translational modiﬁcation, including acetyla-
tion, phosphorylation, or ubiquitination.
Ubiquitination mediates many biological events, including
apoptosis [4,5]. Triad 1 (2 RING [really interesting new gene] ﬁn-
gers and DRIL [double RING ﬁnger linked] 1) is an E3 ligase that
is highly expressed during granulocyte and monocyte differentia-
tion. With its RING-dependent E3 ligase activity, this protein in-chemical Societies. Published by E
e; DRIL, double RING ﬁnger
ome Research Institute, Kon-
l 143-701, Republic of Korea.
e), ansfgrc@konkuk.ac.kr (S.duces apoptosis and clonogenic inhibition in myeloid cells [6].
However, the RING domains are not required for all Triad 1 func-
tions. In fact, Triad 1 inhibits Gﬁ-1 ubiquitination and proteasomal
degradation in the absence of its RING ligase activity. Gﬁ-1 stabil-
ization induces apoptosis in immature myeloid and hematopoietic
stem cells [7,8]. However, the mechanism of this biological process
remains mostly unknown since the substrate for the E3 ligase
activity of Triad 1 has yet to be identiﬁed [6]. Furthermore, Gﬁ-1
serves various roles in different tissues and cell types [9–11].
Therefore, we hypothesize that, to induce apoptosis, Triad 1 func-
tions via multiple pathways depending on its requirement for RING
ligase. Because p53 is central to the regulation of apoptosis, we
examined the dependence of Triad 1-mediated apoptosis on p53
using cancer cells including MCF7, A549, U2OS, H1299, HCT 116
p53+/+, and HCT 116 p53/ cells which are widely used in p53 re-
lated experiments in vitro.2. Materials and methods
2.1. Plasmid construction
The GFP-Triad 1 and GFP-Triad 1 H158A plasmids were gifts
from Dr. van der Reijden (Netherlands). siRNAs against p53 andlsevier B.V. All rights reserved.
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CA, USA). Control siRNA (sequence: AUGAACGUGAAUUGCUCAAG)
was purchased from Ambion (Austin, TX, USA). To generate the
shTriad 1-expressing plasmids, siRNA oligos were subcloned into
the pSuper-GFP-neo vector. Triad 1A forward: GATCCCCAATTGT
GAGGAAGAGGAAGAATTCAAGAGATTCTTCCTCTTCCTCACAATTTTT-
TT, reverse: GGGTTAACACTCCTTCTCCTTCTT AAGTTCTCTAAGAAG-
GAGAAGGAGTGTTAAAAAAATTCGA; Triad 1B forward: GATCCCC
TTGTGAGGAAGAGGAAGAATTCAAGAGATTCTTCCTCTTCCTCACAA
TTTTT, reverse: GGGAACACTCCTTCTCCTTCTTAAGTTCTCTAAGAAG-
GAGAAG GAGTGTTAAAAATTCGA); control forward: GATCCCCG-
CAAGCTGACCTGAAGTTCATTTCAAGAGAATGAACTTCAGGGTA
GAGAGTTGCTTTTT, reverse: GGGCGTTCGACTGGACTTCAAGTAAA-
GTTCTCT TACTTGAAGTCCCATCTCTCAACGAAAAATTCGA. The pPV-
PUMA FLAG2-Luc vector was a gift from Dr. Bert Vogelstein (Johns
Hopkins University Medical Institutions, USA), and the pcDNA
HA-p53 plasmid was kindly provided by Dr. Gerald M. Cohen
(Leicester University, UK).
2.2. Cell culture, transient transfection, and immunoblotting
MCF7 cells were maintained in Dulbecco’s Modiﬁed Eagle Med-
ium. HCT 116 p53+/+ and HCT 116 p53/ cells were maintained in
McCoy’s Medium. The H1299, A549, and U2OS cell lines were
maintained in RPMI medium supplemented with 10% fetal bovine
serum and 1% penicillin/streptomycin.
For transient transfection, plasmids were transfected using
Hilymax (Dojindo) according to the manufacturer’s protocol. siRNA
transfections were performed using RNAimax (Invitrogen, Carls-
bad, CA, USA) also according to the manufacturer’s instructions.
Immunoblot analysis was performed using whole cell extracts that
were lysed in SDS lysis buffer and then boiled for 10 min in 5
sample buffer. Proteins were separated on 10–15% SDS polyacryl-
amide gels and then electrotransferred onto nitrocellulose mem-
branes. The membranes were blocked with 5% skim milk for 1 h
and incubated with primary antibody for 2 h at room temperature
or overnight at 4 C. After incubation, the membranes were washed
three times with TBST (TBS containing 0.05% Tween 20) and incu-
bated with HRP-conjugated a-mouse, -rabbit, or -goat secondary
antibody for 1 h at room temperature. Bands were detected by
enhanced chemiluminescence using Westpico solutions (Pierce,
Rockford, IL). Primary antibodies included mouse monoclonal
anti-p53 and goat polyclonal anti-Gﬁ-1 antibodies, which were
purchased from Santa Cruz Biotechnology. Rabbit polyclonal
antibody against GFP was purchased from Cell Signaling Technol-
ogy (Danvers, MA, USA). Mouse monoclonal antibody against
b-actin was purchased from Sigma–Aldrich (St. Louis, MO, USA).
Rabbit polyclonal antibody speciﬁc to Triad 1 was generated by
Labfrontier (Seoul, Korea) using the peptide sequence N-EN-
QMHIAEQRRRTL-C conjugated to Keyhole Limpet Hemocyanine
(KLH).
2.3. Colony formation assay
Cells were plated in 60-mm dishes and transfected with 500 ng
of plasmid. The cells were incubated for 24 h and then selected
with G418 (500 lg/ml) for 14 days. Then the cells were ﬁxed and
stained with crystal violet.
2.4. Viability assay
For cell viability analysis, cells were trypsinized for the indi-
cated times after transfection and then stained with 4% trypan blue
solution (Invitrogen). The cells were counted using a hemacytom-
eter. The Cell Titer 96 AQueous Non-Radioactive Cell Proliferation
Assay (Promega) was also performed. Cells were incubated withappropriate solution for 1 h prior to measurement of the O.D. at
490 nm for the MTS assay using a Biotek synergy HT microplate
reader. For analysis of apoptosis, DNA content was determined
by propidium iodide (50 lg/ml propidium iodine, 0.1 mg/ml RNase
A, 0.05% Triton X 100) staining followed by ﬂow cytometry. The
Apo-ONE Homogeneous Caspase-3/7 Assay Kit (Promega, Madi-
son, WI, USA) was used according to the manufacturer’s protocol
to measure caspase 3 and 7 activities.
2.5. Luciferase assay
Aliquots of 5  104 cells were plated into 24-well plates. The
following was added to each well: 100 ng of pPV vector encoding
the p53 binding site from the puma promoter, 100 ng of p53-
expressing plasmid, and 200 ng of plasmid expressing the wild-
type or mutant RING domain of Triad 1. At 48 h after transfection,
the cells were harvested and lysed by adding passive lysis buffer.
The luciferase activities driven by p53 binding element were
analyzed using Luciferase Assay System (Takara-Clontech). The
relative luciferase activities were normalized by measuring b-
galactosidase activities using Luminescent b-galactosidase detec-
tion kit II (Takara-Clontech).
2.6. Statistical analysis
Statistical analysis was performed using the two-tailed Stu-
dent’s t test. Statistical signiﬁcance was determined as P < 0.05.3. Results
3.1. Triad 1 induces apoptosis and clonogenic inhibition in MCF7 cells
Previous studies have demonstrated that Triad 1 induces apop-
tosis in myeloid cells [6]. As such, we examined whether Triad 1
also triggers apoptosis in other cell types. Ectopic expression of
Triad 1 in MCF7 cells resulted in cell growth inhibition (Fig. 1A).
However, the Triad 1 H158Amutant, which lacks RING ligase activ-
ity [6], did not affect cellular growth, suggesting that this domain
of Triad 1 is involved in inhibiting MCF7 growth. Immunoblot anal-
ysis demonstrated that GFP-Triad 1 and GFP-Triad 1 H158A
expression was comparable in MCF7 cells (Fig. 1F). Inhibition of
MCF7 cell growth continued for 10 days after transfection (Fig. 1B).
Next, we determined whether Triad 1 inhibited the clonogenic
growth of MCF7 cells. Colony formation assays revealed that
approximately 70% of clonogenic growth was inhibited 48 h after
Triad 1 overexpression (Fig. 1C). Furthermore, we used ﬂow cytom-
etry to examine whether Triad 1 induces apoptosis in MCF7 cells.
Propidium iodide staining was used to assess DNA content 48 h
after transfection with plasmids expressing Triad 1 and the Triad
1 H158A mutant. The percentage of sub-G1 phase cells present fol-
lowing transfection with Triad 1 increased 2.5–3-fold over control
cells and Triad 1 mutant-transfected cells (Fig. 1D). Moreover, the
activities of caspases 3 and 7 increased with Triad 1 transfection,
indicating that Triad 1-induced apoptosis in MCF7 cells (Fig. 1E).
These results suggest that Triad 1 inhibited cellular and clonogenic
growth in MCF7 cells by inducing apoptosis via its RING ligase
activity. Interestingly, the level of Gﬁ-1 was increased by both
Triad 1 and the Triad 1 H158A mutant (Fig. 1F). Moreover, Gﬁ-1
was reduced by Triad 1 knockdown in MCF7 cells (data not shown).
3.2. Triad induces apoptosis in MCF7 cells through a Gﬁ-1-independent
mechanism
Next, we examined whether Gﬁ-1 was also essential for Triad 1-
mediated apoptosis in MCF7 cells. Ablation of Gﬁ-1 by siRNA in the
Fig. 1. Triad 1 induces apoptosis. (A) The viability of MCF7 cells at 48 h after transfection with plasmids expressing GFP, GFP-Triad 1, and Triad 1 mutant H158A was
measured by cell count following trypan blue staining. Error bars indicate the S.E.M. (n = 3). (B) The viability of MCF7 cells after transfection with plasmids expressing GFP,
GFP-Triad 1, and Triad 1 mutant H158A (ligase activity defect) was measured by cell count following trypan blue staining at the indicated times. Error bars indicate the S.E.M.
(n = 3). (C) Colony formation assay in MCF7 cells transfected with plasmids expressing GFP, GFP-Triad 1, and Triad 1 mutant H158A. Cells were stained with crystal violet after
a 14-day culture in G418-containing media. Colony counts are presented in a graph (right panel). (D) Apoptosis of MCF7 cells transfected with plasmids expressing GFP, GFP-
Triad 1, and Triad 1 mutant H158A was measured by ﬂow cytometry. Cells were stained by propidium iodine after transfection. (E) The activities of caspases 3 and 7 were
measured at 48 h after transfection with plasmids expressing GFP, GFP-Triad 1, and Triad 1 mutant H158A in MCF7 cells. Cell lysates were mixed with caspase substrate Z-
DEVD-R110 and the ﬂuorescence was measured (485Ex/527Em) after 12-h incubation at room temperature. (F) The level of exogenous Triad 1 and endogenous Gﬁ-1 were
assessed by immunoblotting. MCF7 cells were transfected with the indicated expression plasmid. Expression of wild-type and mutant Triad 1, as well as endogenous Gﬁ-1,
were measured at 48 h after transfection by immunoblotting with anti-GFP antibody or anti-Gﬁ-1 antibody. b-actin expression was assessed as a loading control.
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growth inhibition (Fig. 2A). In fact, results were similar to those of
control siRNA-transfected cells. Also, caspase 3 and 7 activation by
Triad 1 was not inhibited by Gﬁ-1 ablation (Fig. 2B). Together,
these results indicate that Gﬁ-1 is not involved in Triad 1-mediated
apoptosis in MCF7 cells.We also tested other p53 positive cancer cell lines, A549 and
U2OS. In these experiments, only wild-type Triad 1 promoted cell
growth inhibition while the level of Gﬁ-1 was maintained by both
wild-type and mutant (H158A) Triad 1 (data not shown). These re-
sults imply that the pathway to induce Triad 1-mediated apoptosis
may differ according to the cancer cell line.
Fig. 2. Triad 1 induces apoptosis by a Gﬁ-1-independent mechanism. (A) The
viability of MCF7 cells was measured by cell count following trypan blue staining at
48 h after transfection with control siRNA or Gﬁ-1-speciﬁc siRNA. Error bars
indicate the S.E.M. (n = 3). (B) The activities of caspases 3 and 7 were measured at
48 h after transfection with control siRNA or Gﬁ-1-speciﬁc siRNA in MCF7 cells. Cell
lysates were mixed with caspase substrate Z-DEVD-R110 and the ﬂuorescence was
measured (485Ex/527Em) after 12-h incubation at room temperature.
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RING ligase activity
Next, we tested several cancer cell lines for their sensitivity to
Triad 1-mediated apoptosis. Unexpectedly, while A549, MCF7,
and U2OS cells exhibited similar reductions in viability following
ectopic Triad 1 expression (data not shown), H1299 cells did not
exhibit the same phenotype. Comparison of MCF7 and H1299 via-
bility showed dramatically different sensitivity to apoptosis
(Fig. 3A). H1299 cells do not express p53; therefore, we used arti-
ﬁcial knockdown of p53 and Gﬁ-1 in MCF7 cells to elucidate
whether p53 is involved in Triad 1-mediated apoptosis (Fig. 3B).
The sub-G1 phase in cells containing only a single knockdown
of p53 or Gﬁ-1 in the presence of Triad 1 overexpression was com-
pared. As expected, knockdown of p53 alone and in combination
with Gﬁ-1 resulted in resistance to Triad 1-mediated apoptosis,
whereas single knockdown of Gﬁ-1 had no effect. These results
indicate that Triad 1-mediated apoptosis was p53-dependent butGﬁ-1-independent in MCF7 cells. Conﬁrmation of p53 and Gﬁ-1
knockdown was assessed by immunoblotting (Fig. 3C). Moreover,
we used HCT 116 p53+/+ and HCT 116 p53/ cells to conﬁrm the
involvement of p53 in Triad 1-induced apoptosis. And, only HCT
116 p53+/+ cell growth was inhibited by Triad 1 (Fig. 3D).
Next, we tested whether Triad 1 inﬂuences p53 activation.
Puma is a potential mediator of apoptosis induced by p53 [12].
Thus, to assess p53 activity, the level of Puma expression was
determined by luciferase assay in HCT 116 p53+/+ and HCT 116
p53/ cells after co-transfection with a pPV vector, which encoded
the p53 binding site of the puma promoter, and GFP, GFP-Triad 1,
or GFP-Triad 1 H158A mutant (Fig. 3E). Induction of puma by Triad
1 was detected only in HCT 116 p53+/+ cells, demonstrating that
Triad 1-induced Puma expression was p53-dependent.
Finally, we examined whether Triad 1 was involved in puma
induction by p53. We generated two different shTriad 1-expressing
constructs to knockdown Triad 1. Both shTriad 1 constructs re-
duced the level of endogenous Triad 1 protein (Fig. 3F). As ex-
pected, puma induction by p53 was inhibited by Triad 1 ablation
(Fig. 3G). These results indicated that Triad 1 induces p53-medi-
ated puma expression, and that Triad 1 is required for p53-medi-
ated puma induction. Taken together, our data suggest that Triad
1 induces apoptosis via its E3 ligase activity by inducing p53 acti-
vation. Fig. 3H depicts a schematic diagram of the proposed Triad
1-mediated apoptosis pathway.
4. Discussion
Ubiquitination is involved in various biological processes,
including apoptosis, metabolism, and differentiation [5]. A recent
study suggested that Triad 1 functions to promote apoptosis in
myeloid cells [6] using its E3 ligase activity. However, the direct
substrate of Triad 1 remains unknown despite knowledge of the
involvement Gﬁ-1 stabilization in myeloid cell apoptosis. Although
Triad 1 can stabilize Gﬁ-1 in MCF 7 cells (Fig. 1F), Gﬁ-1 may not be
involved in apoptosis mediated by Triad 1 and its RING ligase activ-
ity. Because Gﬁ-1 is a double-faced molecule depending on the cell
type and tissue [9], Triad 1 may participate in a novel pathway to
induce apoptosis with its E3 ligase activity. In fact, Triad 1 may
have a different substrate for its apoptotic role. In support of this,
Mdm2 has different substrates depending on its function [13].
With the exception of HCT 116 p53/ and H1299 cells, which
are p53-deﬁcient, ectopic expression of Triad 1 in several cancer
cells resulted in inhibition of cellular or clonogenic growth by
apoptosis induction. These data indicate that p53 plays a role in
Triad 1-mediated apoptosis. p53 is a central molecule involved in
apoptosis [14] that is regulated by various post-translational mod-
iﬁcations [15], including ubiquitination. Our data demonstrating
that Triad 1 induces p53-dependent puma expression with its
RING ligase activity also supports this hypothesis.
p53 undergoes various post-translational modiﬁcations such as
acetylation, phosphorylation, and ubiquitination [15]. These mod-
iﬁcations affect the transcriptional activity of p53 [16]. Due to the
cytotoxic effect of p53, it normally undergoes rapid degradation
through a ubiquitin-mediated proteasome mechanism involving
several E3 ligases including Mdm2 [17]. Ubiquitination of p53 neg-
atively regulates transactivation by inhibiting acetylation of the
protein and its export to the cytoplasm [18–20]. Moreover, once
ubiquitinated, cytoplasmic p53 cannot induce transcription-inde-
pendent cell death [20] neither localize to the nucleus [21]. There-
fore, deubiquitination of p53 by USP7 or USP10 are indispensible
for p53 transcription and transcription-independent cell death
[20,22]. The levels of apoptotic genes, including puma and bax,
are also reduced by E4F1-mediated p53 ubiquitination [23]. These
reports indicate that p53 ubiquitination negatively regulates both
p53 transcription-dependent and -independent cell death. Triad
Fig. 3. Triad 1 induces apoptosis by enhancing p53 transactivation. (A) The viability of MCF7 and H1299 cells after 48 h of transfection with plasmids expressing GFP (black
bar), GFP-Triad 1 (dark gray bar), or GFP-Triad 1 H158A mutant (gray bar) was measured by the MTS assay. Error bars indicate the S.E.M. (n = 6). (B) The viability of MCF7 cells
was measured by ﬂow cytometry analysis at 48 h after transfection with control siRNA or siRNA against p53 or Gﬁ-1 in the presence of wild-type or mutant Triad 1. Cells were
stained with propidium iodine after transfection. (C) The levels of exogenous Triad 1 and endogenous p53 and Gﬁ-1 were measured by immunoblotting. MCF7 cells were
transfected with the indicated expression plasmid or siRNA. Ectopic expression of wild-type and mutant Triad 1 were assessed 24 h later by immunoblotting with anti-GFP
antibody. The endogenous levels of p53 and Gﬁ-1 were measured by immunoblotting with anti-p53 or anti-Gﬁ-1 antibody. The level of -actin was examined as a loading
control. (D) The viability of HCT 116 p53+/+ and HCT 116 p53/ cells after transfection with plasmids expressing GFP or GFP-Triad 1 was measured by the MTS assay. Error
bars indicate the S.E.M. (n = 3). (E) Transcriptional activity of p53 upon ectopic expression of Triad 1 was evaluated by the luciferase assay. HCT 116 p53+/+ and HCT 116 p53/
cells were co-transfected with a Puma-luc expression construct and a plasmid encoding GFP, GFP-Triad 1 or GFP-Triad 1 H158A mutant. At 24 h after transfection, the
luciferase activity was measured in whole cell lysates. Error bars indicate the S.E.M. (n = 6) of three independent experiments. (F) HCT 116 p53+/+ or MCF7 cells were
transfected with Triad 1 shRNA. After 48 h, the level of Triad 1 protein was assessed by immunoblotting with anti-Triad 1 antibody. b-actin expression was analyzed as a
loading control. (G) p53 transcriptional activity following Triad 1 knockdown was evaluated by the luciferase assay. HCT 116 p53+/+ or MCF7 cells were co-transfected with
the Puma-luc expression construct and control or Triad 1A, HA-p53-encoding plasmid. At 24 h after transfection, luciferase activity was measured in whole cell lysates. Error
bars indicate the S.E.M. (n = 6) of three independent experiments. (H) A schematic diagram of the proposed pathways of Triad 1-mediated apoptosis. Triad 1 induces apoptosis
by two different pathways. One is RING ligase-independent and occurs through Gﬁ-1 stabilization in myeloid cells. The other requires the RING ligase activity of Triad 1 and
p53 activation. The latter pathway has been demonstrated in this study in several cancer cells including MCF7, A549, U2OS, and HCT 116 p53+/+ cells.
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1570 J.H. Jung et al. / FEBS Letters 584 (2010) 1565–15701-induced cell death is p53-dependent and occurs through its RING
ligase activity. Triad 1 also induces puma expression via p53.
Therefore, it is likely that Triad 1 may activate p53 indirectly via
its E3 ligase. Such a models, in which Mdm2 autoubiquitination
by USP7 also induces apoptosis via p53 activation [24]. Also inhibi-
tion of various molecules that negatively regulate p53 function,
including SIRT1, results in apoptosis by p53 activation [25], there-
by providing additional support that ubiquitination can lead indi-
rectly to p53 activation.
The level of Triad 1 mRNA is strongly induced by all-trans reti-
noic acid (ATRA) in NB4 cells [6]. Interestingly, the p53 apoptotic
pathway is induced by ATRA in acute myeloblastic leukemia cells
[26]. Moreover, studies have shown that the levels of p53 and pro-
caspase sensitization are induced by ATRA in keratinocytes [27].
These reports support our data showing that Triad 1, which is also
induced by ATRA, upregulates Puma in a p53-dependent manner.
Moreover, ablation of Triad 1 attenuates p53-mediated puma
induction, suggesting that Triad 1 may be required for p53
transactivation.
Here we demonstrate that Triad 1 induces apoptosis via its
RING ligase activity by enhancing p53 transactivation. Triad 1 is
capable of inducing apoptosis in various cell types, and whether
its RING ligase activity is involved differs depending on the path-
way (Fig. 3H). Further studies of p53 regulation by Triad 1 are still
required to fully elucidate the mechanisms of these pathways.
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